The Business Model of GlaxoSmithKline

GlaxoSmithKline is a global British healthcare company specializing in developing pharmaceuticals, vaccines, and consumer healthcare products. Being one of the largest pharmaceutical companies, GSK offers a portfolio of products for the three primary areas pharmaceuticals, vaccines, and consumer healthcare. GSK was formed in 2000 by the merger of GlaxoWellcome plc with SmithKline Beecham plc. During the recent years, the company underwent many changes in order to put patients first and improve access to medicines by using its huge global reach and impact. It transformed its business model by accelerating R&D, opening up research, and exploring new strategies for distribution and partnerships.